WTA: Chris Evert receiving treatment for cancer recurrence

Date:

Share post:


Tennis great Chris Evert is dealing with a recurrence of ovarian cancer, and treatments will keep her off television broadcasts of the upcoming Australian Open.

“While this is a diagnosis I never wanted to hear, I once again feel fortunate that it was caught early,” Evert said in a statement issued through ESPN, for whom she is an analyst. “Doctors found cancer cells in the same pelvic region. All cells were removed, and I have begun another round of chemotherapy.

“I will be unable to join my colleagues when ESPN makes its return to Melbourne for the Australian Open next month. But I’ll be ready for the rest of the Grand Slam season!

“I encourage everyone to know your family history and advocate for yourself. Early detection saves lives. Be thankful for your health this holiday season.”

Evert, 68, was first diagnosed with ovarian cancer in 2021.

Evert captured 18 career Grand Slam singles titles: two at the Australian Open, seven at the French Open, three at Wimbledon and six at the U.S. Open. She added three major doubles championships and helped the United States win the Fed Cup eight times.

After a pro career that ran from 1972-89, Evert was enshrined in the International Tennis Hall of Fame in 1995.

–Field Level Media

spot_img

Related articles

WTA: Poland, Great Britain advance to Billie Jean King Cup quarters

Iga Swiatek and Magda Linette won singles matches to lead Poland to a 2-0 victory over host Spain...

ATP: Alexander Zverev, Casper Ruud advance to Nitto ATP semifinals

Alexander Zverev and Casper Ruud will round out the semifinals of the Nitto ATP Finals after each won...

WTA: Billie Jean King Cup: Slovakia knocks out U.S.

The United States bowed out of the Billie Jean King Cup finals in the first round with a...

ATP: Jannik Sinner, Taylor Fritz to semis at Nitto ATP Finals

Jannik Sinner and Taylor Fritz are moving on to the semifinal round of the Nitto ATP Finals after...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.